A New Approach for the Diagnosis of Myelodysplastic Syndrome Subtypes Based on Protein Interaction Analysis

[1]  Matthias Mann,et al.  Revisiting biomarker discovery by plasma proteomics , 2017, Molecular systems biology.

[2]  J. Čermák,et al.  Enhanced plasma protein carbonylation in patients with myelodysplastic syndromes , 2017, Free radical biology & medicine.

[3]  A. Tefferi,et al.  Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis (RARS‐T): 2017 update on diagnosis, risk‐stratification, and management , 2017, American journal of hematology.

[4]  C. Borrebaeck.  Precision diagnostics: moving towards protein biomarker signatures of clinical utility in cancer , 2017, Nature Reviews Cancer.

[5]  F. Solé,et al.  Computational drug treatment simulations on projections of dysregulated protein networks derived from the myelodysplastic mutanome match clinical response in patients. , 2017, Leukemia research.

[6]  Michelle C. Chen,et al.  Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9 , 2016, Nature Medicine.

[7]  A panel of glycoproteins as candidate biomarkers for early diagnosis and treatment evaluation of B-cell acute lymphoblastic leukemia , 2016, Biomarker Research.

[8]  F. Berven,et al.  Global Cell Proteome Profiling, Phospho-signaling and Quantitative 
Proteomics for Identification of New Biomarkers in Acute Myeloid 
Leukemia Patients , 2015, Current pharmaceutical biotechnology.

[9]  G. Mufti,et al.  The Proinflammatory Protein S100A9 Suppresses Erythropoietin Elaboration in Patients with Myelodysplastic Syndromes , 2015 .

[10]  Yanxia Wang,et al.  Effects of down-regulation of clusterin by small interference RNA on human acute myeloid leukemia cells. , 2015, International journal of clinical and experimental medicine.

[11]  J. Čermák,et al.  Plasma Protein Biomarker Candidates for Myelodysplastic Syndrome Subgroups , 2015, BioMed research international.

[12]  J. Homola,et al.  Rapid and sensitive detection of multiple microRNAs in cell lysate by low-fouling surface plasmon resonance biosensor. , 2015, Biosensors & bioelectronics.

[13]  Jiří Homola,et al.  Biosensor Enhancement Using Grooved Micromixers: Part II, Experimental Studies. , 2015, Analytical chemistry.

[14]  J. Konvalinka,et al.  Structural and Biochemical Characterization of a Novel Aminopeptidase from Human Intestine* , 2015, The Journal of Biological Chemistry.

[15]  W. Xu,et al.  LRG1 is an independent prognostic factor for endometrial carcinoma , 2014, Tumor Biology.

[16]  V Srinivasa Rao,et al.  Protein interaction network for Alzheimer's disease using computational approach , 2013, Bioinformation.

[17]  C. Mantzoros,et al.  Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome. , 2013, Metabolism: clinical and experimental.

[18]  Sheng Wei,et al.  Induction of myelodysplasia by myeloid-derived suppressor cells. , 2013, The Journal of clinical investigation.

[19]  M. Cazzola,et al.  Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet. , 2013, Blood.

[20]  P. Chaurand,et al.  Non-specific adsorption of crude cell lysate on surface plasmon resonance sensors. , 2013, Langmuir : the ACS journal of surfaces and colloids.

[21]  Maricel G. Kann,et al.  Chapter 4: Protein Interactions and Disease , 2012, PLoS Comput. Biol..

[22]  Sheng Wei,et al.  Microenvironment Induced Myelodysplastic Syndrome (MDS) in S100A9 Transgenic Mice Caused by Myeloid-Derived Suppressor Cells (MDSC) , 2011 .

[23]  J. Homola,et al.  Surface plasmon resonance biosensor for the detection of VEGFR-1—a protein marker of myelodysplastic syndromes , 2011, Analytical and Bioanalytical Chemistry.

[24]  Marek Piliarik,et al.  Surface plasmon resonance biosensor for parallelized detection of protein biomarkers in diluted blood plasma. , 2010, Biosensors & bioelectronics.

[25]  E. Wright,et al.  Identification of disease- and therapy-associated proteome changes in the sera of patients with myelodysplastic syndromes and del(5q) , 2010, Leukemia.

[26]  Jiří Homola,et al.  An SPR biosensor for the detection of microcystins in drinking water , 2010, Analytical and bioanalytical chemistry.

[27]  Marek Piliarik,et al.  Surface plasmon resonance sensor with dispersionless microfluidics for direct detection of nucleic acids at the low femtomole level , 2010 .

[28]  Y. Okahata,et al.  Kinetic analyses for bindings of concanavalin A to dispersed and condensed mannose surfaces on a quartz crystal microbalance. , 2009, Analytical biochemistry.

[29]  P. Nguyen,et al.  Myelodysplastic syndromes , 2009, Nature Reviews Disease Primers.

[30]  A. Tefferi,et al.  Myelodysplastic syndromes. , 2009, The New England journal of medicine.

[31]  J. Homola.  Surface Plasmon Resonance Sensors for Detection of Chemical and Biological Species , 2008 .

[32]  J. Jones,et al.  A review of the S100 proteins in cancer. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[33]  A. Scholten,et al.  Surface‐Plasmon‐Resonance‐Based Chemical Proteomics: Efficient Specific Extraction and Semiquantitative Identification of Cyclic Nucleotide‐Binding Proteins from Cellular Lysates by Using a Combination of Surface Plasmon Resonance, Sequential Elution and Liquid Chromatography–Tandem Mass Spectrometr , 2007, Chembiochem : a European journal of chemical biology.

[34]  Jong Seol Yuk,et al.  Analysis of protein interactions on protein arrays by a novel spectral surface plasmon resonance imaging. , 2006, Biosensors & bioelectronics.

[35]  R. Wells,et al.  Progression of myelodysplasia to acute lymphoblastic leukaemia: implications for disease biology. , 2006, Leukemia research.

[36]  J. Willis,et al.  Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer , 2006, Cell Death and Differentiation.

[37]  F. Giorgini,et al.  Connecting the dots in Huntington's disease with protein interaction networks , 2005, Genome Biology.

[38]  A. Alegakis,et al.  Levels of soluble forms of ICAM and VCAM in patients with myelodysplastic syndromes and their prognostic significance. , 2004, Clinical and laboratory haematology.

[39]  Ryan Okon,et al.  Evaluating sandwich immunoassays in microarray format in terms of the ambient analyte regime. , 2004, Clinical chemistry.

[40]  Emanuel F Petricoin,et al.  Protein microarray detection strategies: focus on direct detection technologies. , 2004, Journal of immunological methods.

[41]  R. Bischoff,et al.  Methodological advances in the discovery of protein and peptide disease markers. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[42]  S. Hanash.  Disease proteomics : Proteomics , 2003 .

[43]  S. Hanash,et al.  Disease proteomics , 2003, Nature.

[44]  Gavin MacBeath,et al.  Protein microarrays and proteomics , 2002, Nature Genetics.

[45]  L. Druhan,et al.  Molecular characterization and expression analysis of leucine‐rich α2‐glycoprotein, a novel marker of granulocytic differentiation , 2002, Journal of leukocyte biology.

[46]  R. Oyama,et al.  Novel fluorescence labeling and high-throughput assay technologies for in vitro analysis of protein interactions. , 2002, Genome research.

[47]  U. Germing,et al.  Levels of circulating endothelial adhesion molecules in patients with myelodysplastic syndromes. , 2002, International journal of oncology.

[48]  W. Webb,et al.  Molecular dynamics in living cells observed by fluorescence correlation spectroscopy with one- and two-photon excitation. , 1999, Biophysical journal.

[49]  Günter Gauglitz,et al.  Surface plasmon resonance sensors: review , 1999 .

[50]  T. Tötterman,et al.  Elevated serum levels of soluble vascular cell adhesion molecule‐1 (sVCAM‐1) closely reflect tumour burden in chronic B‐lymphocytic leukaemia , 1998, British journal of haematology.